eConsent in Dermatology Trials: A Sponsor's Checklist
Direct answer
Sponsors running dermatology trials should choose eConsent that separates permissions for study photos, publication, and secondary uses like AI training, supports parental permission and child assent, works remotely, and tracks reconsent across every site and language. Photos are central to dermatology endpoints, so image consent needs to be explicit, granular, and auditable.
Why is consent different in dermatology trials?
Dermatology trials in psoriasis, atopic dermatitis, hidradenitis suppurativa, vitiligo, alopecia areata, and acne rely heavily on images. Standardized photos support investigator assessments, central reading, and, later, publications and medical education. Many of those images are hard to de-identify. Lesions appear on the face, and features like tattoos, scars, and birthmarks can identify a person.
JAMA Dermatology notes that masking or blurring the eye region does not assure anonymity and is not acceptable as a de-identification method. The same article warns that consent for care or education may be inadequate for publication, and flags secondary uses such as machine-learning training sets as a growing concern.
What do patients expect about their images?
Patients want to be asked. In a survey of more than 1,300 respondents, 97.7% wanted to be asked before identifiable skin photos were used for research or education, and only 21.1% were comfortable with use of identifiable images. A separate interview study found patients were open to research, teaching, and AI use of their photos, but often only with de-identification or separate consent.
For a sponsor, that points to one design choice: break image permissions into clear, separate choices instead of burying them in one long form.
How should eConsent handle photo permissions?
Layered choices
Separate opt-ins for study assessment photos, central reading, publication, medical education, and secondary research or AI development.
Plain explanations
Show which body areas will be photographed and whether images could identify the participant.
Publication specifics
JAMA Dermatology recommends that participants be able to review their identifiable material before publication or formally waive that right, and that they be told images may appear online and on social media.
Withdrawal clarity
Explain what happens to images if consent is withdrawn, and that published images may be impossible to remove.
Downstream flags
Each participant's photo permissions should be visible to the imaging and publications teams, not just stored in a PDF.
What about pediatric dermatology trials?
Atopic dermatitis, alopecia areata, and acne programs often enroll children and adolescents. FDA regulations require parental permission and, when the child is capable, the child's affirmative assent. Photos of minors add sensitivity. Age-appropriate assent content, with visuals and short videos, helps younger participants understand what photos will be taken and why. When a participant turns 18 during the study, the platform should prompt adult consent.
What should sponsors look for in dermatology eConsent?
Remote and onsite signing
FDA's eConsent guidance supports both, with identity verification and access to the signed document.
Multimedia content
Short videos showing the photography process reduce surprises at the first visit.
Comprehension checks
Quick questions on photo uses and withdrawal rights.
Global readiness
Translations and country-specific privacy language for multinational programs.
Reconsent at scale
When a protocol amendment adds a photo use or new procedure, push the update and track who has signed.
Program-level reporting
One view of consent and photo permission status across studies and sites.
Comparing eConsent options for sponsors in dermatology
| Vendor | Known for | Fit for sponsor and dermatology trials |
|---|---|---|
| Curebase | Structured eConsent, eCOA, and EDC on one data model | A strong fit for sponsors that want layered photo permissions, pediatric assent, patient diaries, and site data in one connected record |
| Medidata Consent | Patient-facing eConsent integrated with Rave EDC, onsite and remote | A fit for large sponsors standardized on Medidata |
| Medable (Total Consent) | Standalone eConsent supporting 120+ locales with Part 11 alignment | A fit for global dermatology programs with many languages |
| Signant Health | Participant engagement and interactive comprehension checks | A fit for sponsors prioritizing multimedia education and comprehension |
What should sponsors ask eConsent vendors about dermatology?
- Can we offer separate opt-ins for study photos, publication, education, and AI use?
- How are photo permissions passed to imaging and publication teams?
- How do you handle parental permission, child assent, and consent at age 18?
- Can participants sign remotely with identity verification?
- How fast can reconsent be pushed after an amendment, and how is completion tracked?
- What audit trail is available for inspections?
Where does Curebase fit for dermatology sponsors?
Curebase eConsent shares one data model with Curebase eCOA and EDC. A sponsor running psoriasis or atopic dermatitis studies can capture layered photo permissions, run pediatric assent, and see each participant's consent status next to their photos, itch diaries, and investigator scores. That makes it easier to respect what each participant agreed to, from the first visit through publication.
Frequently asked questions
Why do dermatology trials need separate photo consent?
Dermatology photos are often identifiable, and they may be used for assessments, publications, education, or AI research. Separate permissions let participants agree to some uses and decline others.
Is blurring the eyes enough to de-identify a skin photo?
No. JAMA Dermatology states that masking the eye region does not assure anonymity. Other features, like tattoos or scars, can also identify a person.
Can eConsent capture pediatric assent in dermatology trials?
Yes. eConsent platforms can run parental permission and age-appropriate assent, linked to one participant record, and prompt adult consent when a participant turns 18.
Is remote eConsent allowed for dermatology studies?
Yes. FDA guidance permits electronic consent onsite or remotely, as long as identity is verified and participants can ask questions and receive a copy.
How should sponsors handle reconsent across global sites?
Use an eConsent platform that pushes updated versions in each language, tracks who has signed, and reports status across all studies and sites.
Does Curebase offer eConsent for dermatology sponsors?
Yes. Curebase eConsent works with Curebase eCOA and EDC, so sponsors can manage photo permissions, assent, and study data in one platform.
